Biren Amin
Stock Analyst at Piper Sandler
(4.47)
# 1,136
Out of 4,974 analysts
644
Total ratings
47.7%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Reiterated: Buy | $21 | $4.88 | +330.33% | 10 | Sep 9, 2026 | |
| ACRS Aclaris Therapeutics | Reiterated: Buy | $11 | $5.53 | +99.10% | 7 | Aug 31, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $115 | $68.39 | +68.15% | 35 | Aug 31, 2026 | |
| OKYO OKYO Pharma | Reiterated: Buy | $7 | $1.34 | +422.39% | 3 | Aug 27, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $31 | $10.19 | +204.22% | 27 | Aug 26, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $140 | $113.15 | +23.73% | 3 | Aug 20, 2026 | |
| ALLO Allogene Therapeutics | Reiterated: Buy | $10 | $1.72 | +481.40% | 23 | Aug 13, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $1.17 | +498.29% | 2 | Aug 13, 2026 | |
| IMNM Immunome | Reiterated: Buy | $33 | $23.95 | +37.79% | 16 | Aug 12, 2026 | |
| JSPR Jasper Therapeutics | Initiated Coverage: Buy | $2 | $0.5701 | +250.82% | 1 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $7 | $4.23 | +65.48% | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $5.06 | +137.15% | 11 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 → $14 | $2.73 | +412.82% | 9 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $6 | $1.85 | +224.32% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.82 | +89.00% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $20.72 | -3.47% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $29.95 | +137.06% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $855 → $854 | $774.11 | +10.32% | 46 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $104.33 | -3.19% | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $18.80 | +86.17% | 24 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.3644 | +1,820.97% | 8 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $16.00 | +200.00% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $24.83 | +40.96% | 10 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $8.37 | +115.05% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $7 | $3.20 | +118.75% | 3 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $51 | $6.92 | +636.99% | 4 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $0.7 | $0.365 | n/a | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $70 | $3.13 | n/a | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $142 → $94 | $150.02 | n/a | 44 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $17.67 | n/a | 4 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.314 | n/a | 20 | Jul 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $19 | $8.60 | n/a | 2 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $7 | $7.16 | n/a | 11 | Mar 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $51 | $3.43 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $59 → $34 | $28.85 | n/a | 2 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $2.05 | n/a | 5 | Feb 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $32 | $3.67 | n/a | 2 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 → $109 | $2.35 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $60 | $9.36 | n/a | 18 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.89 | n/a | 3 | Dec 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $10 | $0.5077 | n/a | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $9 | $2.69 | n/a | 12 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 → $18 | $46.03 | n/a | 32 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $59.21 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $3.83 | n/a | 4 | May 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $0.0003 | n/a | 1 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $11 | $3.40 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $54.68 | n/a | 10 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3.5 | $8.14 | n/a | 4 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10 → $1 | $0.0004 | n/a | 19 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $7.5 | $38.51 | n/a | 19 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $26 | $0.0001 | n/a | 3 | Jun 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $17 | $12.95 | n/a | 1 | Jun 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $151.22 | n/a | 1 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $155 | $514.63 | n/a | 1 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $4.86 | n/a | 1 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $1.61 | n/a | 7 | Jun 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.673 | n/a | 9 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $15 | $33.69 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $8.75 | $15.84 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 | $7.34 | n/a | 7 | Jan 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.000001 | n/a | 1 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $56.28 | n/a | 7 | Mar 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $1.34 | n/a | 1 | Feb 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 → $7 | $1.19 | n/a | 6 | Oct 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $0.1831 | n/a | 1 | Aug 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $66.64 | n/a | 7 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $4 | $56.90 | n/a | 2 | May 2, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $146.30 | n/a | 1 | Jan 27, 2010 |
BridgeBio Oncology Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $21
Current: $4.88
Upside: +330.33%
Aclaris Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $11
Current: $5.53
Upside: +99.10%
BridgeBio Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $115
Current: $68.39
Upside: +68.15%
OKYO Pharma
Aug 27, 2026
Reiterated: Buy
Price Target: $7
Current: $1.34
Upside: +422.39%
Ocular Therapeutix
Aug 26, 2026
Reiterated: Buy
Price Target: $31
Current: $10.19
Upside: +204.22%
Kymera Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $140
Current: $113.15
Upside: +23.73%
Allogene Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.72
Upside: +481.40%
Connect Biopharma Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $1.17
Upside: +498.29%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $33
Current: $23.95
Upside: +37.79%
Jasper Therapeutics
Aug 12, 2026
Initiated Coverage: Buy
Price Target: $2
Current: $0.5701
Upside: +250.82%
Aug 12, 2026
Reiterated: Hold
Price Target: $12 → $7
Current: $4.23
Upside: +65.48%
Aug 12, 2026
Reiterated: Buy
Price Target: $12
Current: $5.06
Upside: +137.15%
Aug 11, 2026
Rated: Buy
Price Target: $16 → $14
Current: $2.73
Upside: +412.82%
Aug 7, 2026
Reiterated: Buy
Price Target: $4 → $6
Current: $1.85
Upside: +224.32%
Aug 7, 2026
Reiterated: Buy
Price Target: $11
Current: $5.82
Upside: +89.00%
Aug 6, 2026
Reiterated: Hold
Price Target: $20
Current: $20.72
Upside: -3.47%
Jul 30, 2026
Reiterated: Buy
Price Target: $71
Current: $29.95
Upside: +137.06%
Jul 9, 2026
Rated: Buy
Price Target: $855 → $854
Current: $774.11
Upside: +10.32%
Jun 29, 2026
Reiterated: Buy
Price Target: $101
Current: $104.33
Upside: -3.19%
Jun 23, 2026
Reiterated: Buy
Price Target: $35
Current: $18.80
Upside: +86.17%
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $0.3644
Upside: +1,820.97%
Jun 1, 2026
Reiterated: Buy
Price Target: $48
Current: $16.00
Upside: +200.00%
May 13, 2026
Reiterated: Buy
Price Target: $35
Current: $24.83
Upside: +40.96%
May 13, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $8.37
Upside: +115.05%
Mar 30, 2026
Reiterated: Hold
Price Target: $5 → $7
Current: $3.20
Upside: +118.75%
Oct 20, 2025
Reiterated: Buy
Price Target: $35 → $51
Current: $6.92
Upside: +636.99%
Mar 21, 2025
Downgraded: Hold
Price Target: $10 → $0.7
Current: $0.365
Upside: n/a
May 19, 2023
Reiterated: Buy
Price Target: $63 → $70
Current: $3.13
Upside: n/a
Mar 3, 2022
Downgraded: Hold
Price Target: $142 → $94
Current: $150.02
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $56
Current: $17.67
Upside: n/a
Jul 23, 2021
Reiterated: Buy
Price Target: $25
Current: $0.314
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $14 → $19
Current: $8.60
Upside: n/a
Mar 15, 2021
Rated: Buy
Price Target: $8 → $7
Current: $7.16
Upside: n/a
Mar 12, 2021
Reiterated: Buy
Price Target: $34 → $51
Current: $3.43
Upside: n/a
Feb 16, 2021
Downgraded: Hold
Price Target: $59 → $34
Current: $28.85
Upside: n/a
Feb 10, 2021
Reiterated: Buy
Price Target: $21
Current: $2.05
Upside: n/a
Jan 15, 2021
Reiterated: Buy
Price Target: $27 → $32
Current: $3.67
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $39 → $109
Current: $2.35
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: $43 → $60
Current: $9.36
Upside: n/a
Dec 9, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.89
Upside: n/a
Sep 14, 2020
Downgraded: Hold
Price Target: $15 → $10
Current: $0.5077
Upside: n/a
Aug 7, 2020
Reiterated: Hold
Price Target: $10 → $9
Current: $2.69
Upside: n/a
Jul 29, 2020
Reiterated: Hold
Price Target: $36 → $18
Current: $46.03
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: $41
Current: $59.21
Upside: n/a
May 29, 2020
Downgraded: Hold
Price Target: $18 → $2
Current: $3.83
Upside: n/a
Mar 27, 2020
Initiated Coverage: Buy
Price Target: $6
Current: $0.0003
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $6 → $11
Current: $3.40
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $12
Current: $54.68
Upside: n/a
Nov 12, 2018
Reiterated: Hold
Price Target: $4 → $3.5
Current: $8.14
Upside: n/a
Oct 10, 2018
Downgraded: Hold
Price Target: $10 → $1
Current: $0.0004
Upside: n/a
Aug 10, 2018
Reiterated: Hold
Price Target: $15 → $7.5
Current: $38.51
Upside: n/a
Jun 18, 2018
Reiterated: Buy
Price Target: $21 → $26
Current: $0.0001
Upside: n/a
Jun 5, 2018
Initiated Coverage: Buy
Price Target: $17
Current: $12.95
Upside: n/a
Mar 19, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $151.22
Upside: n/a
Jul 11, 2017
Initiated Coverage: Buy
Price Target: $155
Current: $514.63
Upside: n/a
Jun 22, 2017
Reiterated: Buy
Price Target: $17
Current: $4.86
Upside: n/a
Jun 6, 2017
Reiterated: Buy
Price Target: $47
Current: $1.61
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $3
Current: $0.673
Upside: n/a
Mar 10, 2017
Reiterated: Hold
Price Target: $9 → $15
Current: $33.69
Upside: n/a
Jan 18, 2017
Downgraded: Hold
Price Target: $6 → $8.75
Current: $15.84
Upside: n/a
Jan 12, 2017
Reiterated: Hold
Price Target: $1.5
Current: $7.34
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $9
Current: $0.000001
Upside: n/a
Mar 9, 2016
Reiterated: Buy
Price Target: $12 → $11
Current: $56.28
Upside: n/a
Feb 22, 2016
Reiterated: Buy
Price Target: $15
Current: $1.34
Upside: n/a
Oct 30, 2015
Rated: Buy
Price Target: $6 → $7
Current: $1.19
Upside: n/a
Aug 22, 2014
Downgraded: Hold
Price Target: $5
Current: $0.1831
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $15
Current: $66.64
Upside: n/a
May 2, 2014
Rated: Hold
Price Target: $6 → $4
Current: $56.90
Upside: n/a
Jan 27, 2010
Reiterated: Buy
Price Target: $29
Current: $146.30
Upside: n/a